Teva Pharmaceutical Industries (TEVA) Return on Assets: 2009-2025
Historic Return on Assets for Teva Pharmaceutical Industries (TEVA) over the last 15 years, with Sep 2025 value amounting to 0.02%.
- Teva Pharmaceutical Industries' Return on Assets rose 8.00% to 0.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02%, marking a year-over-year increase of 8.00%. This contributed to the annual value of -0.05% for FY2024, which is 3.00% down from last year.
- Per Teva Pharmaceutical Industries' latest filing, its Return on Assets stood at 0.02% for Q3 2025, which was up 486.91% from -0.00% recorded in Q2 2025.
- In the past 5 years, Teva Pharmaceutical Industries' Return on Assets ranged from a high of 0.02% in Q3 2025 and a low of -0.08% during Q1 2021.
- In the last 3 years, Teva Pharmaceutical Industries' Return on Assets had a median value of -0.05% in 2024 and averaged -0.04%.
- Over the last 5 years, Teva Pharmaceutical Industries' Return on Assets had its largest YoY gain of 10bps in 2021, and its largest YoY loss of 8bps in 2021.
- Quarterly analysis of 5 years shows Teva Pharmaceutical Industries' Return on Assets stood at 0.01% in 2021, then fell by 7bps to -0.06% in 2022, then declined by 1bps to -0.07% in 2023, then grew by 4bps to -0.03% in 2024, then rose by 8bps to 0.02% in 2025.
- Its Return on Assets was 0.02% in Q3 2025, compared to -0.00% in Q2 2025 and -0.03% in Q1 2025.